INTRODUCTION
============

Hip pain in the young adult is frequently attributed to soft tissue groin or hip strains. However, an increasingly recognized source of pain and hip dysfunction in this population is femoroacetabular impingement (FAI). FAI results from repetitive abnormal contact of the femoral head and neck against the acetabulum. This condition occurs more frequently in athletes as repetitive hip movements are associated with developmental bony alterations resulting in this condition \[[@hnv048-B1]\]. Evidence has shown an association of FAI-related groin pain with the development of osteoarthritis (OA) of the hip \[[@hnv048-B4]\].

There is evidence to suggest that surgical interventions, through either open or arthroscopic approaches, may prevent worsening of symptoms and progression of osteoarthritis. Operative success is measured by using objective measures such as: radiologic imaging of deformity correction, and improvements in range of motion \[[@hnv048-B7]\]. Additionally, standardized hip outcome scores are frequently used in the literature including the modified Harris Hip Score (mHHS), Hip Outcome score Activities of Daily Living (HOS-ADL), HOS-Sport-Specific Subscales (HOS-SSS), 12-item Short Form Health Survey (SF-12) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) \[[@hnv048-B8]\].

Wile these scores have been validated, they were originally designed for assessing advanced OA in older populations and do not account for the high impact activities that young adult athletes with FAI will demand of their hips post-operatively \[[@hnv048-B1], [@hnv048-B8]\]. New outcome measures have been developed such as the Non-Arthritic Hip Score (NAHS), Hip Outcome Score (HOS), the International Hip Outcome Tool-33 (IHOT-33) and the Copenhagen Hip and Groin Outcome Score (HAGOS). Many of these of outcome measures have even undergone cross cultural adaptations for assessment of specific populations \[[@hnv048-B11], [@hnv048-B12]\]. Lodhia *etal.* \[[@hnv048-B8]\] identified Hip Outcome Score, WOMAC and NAHS as reliable measures to identify outcomes in FAI. In particular, HOS was identified as the most proven instrument for use in this population \[[@hnv048-B8]\].

The iHOT-33 was developed using a large sample size of young and active patients \[[@hnv048-B13]\]. The iHOT-33 aims to improve upon the responsiveness of the WOMAC, HOS, HAGOS and other hip scores as a primary objective measure \[[@hnv048-B13]\]. Impellizzeri *et al.* \[[@hnv048-B14]\] established that defining patient-rated expectations is vital in predicting patient satisfaction with surgery and improving patient-rated outcome (PRO). Consequently, there has been an increased emphasis placed on reporting patient's perspectives and quality of life as the primary objective.

This systematic review aims to ascertain the specific non-hip score outcomes that are being reported in the literature, to determine if the outcomes are being reported consistently. Furthermore, we hope to determine whether the outcomes that patients consider to be most important are the outcomes that are reported most frequently in the literature or if there is often a disconnect between what patients and clinicians consider to be most important. Also, the authors hypothesize that there is a positive relationship between non-hip score outcomes and standardized hip outcome scores.

MATERIALS AND METHODS
=====================

Search strategy
---------------

Two reviewers searched EMBASE, MEDLINE and PubMed for literature related to non-hip score outcomes after surgical treatment of FAI ([Fig. 1](#hnv048-F1){ref-type="fig"}). The database search was conducted on 15 October 2014 and retrieved articles from database inception to the search date. The research question and individual study inclusion and exclusion criteria were established *a priori*. The inclusion criteria were: (i) all levels of evidence; (ii) male and female patients of all ages; (iii) papers published in English; (iv) studies on humans and (v) studies reporting non-hip score outcomes (e.g. patient satisfaction, improvement in pain, return to sport, etc.). Exclusion criteria were: (a) any non-surgical treatment studies (e.g. conservative treatment, technique articles without outcomes, cadaver studies, review articles, etc.); (b) patients with unrelated diagnoses such as osteoarthritis, septic joint, etc. and (c) studies that used the same patient population in order to avoid duplication of patients in the data analysis. In these cases, the study with the larger patient population was included. If a follow-up study of the same patient population was identified, the more recent study was included. Fig. 1.Outline of systematic search strategy used.

The following key terms were used in the search; 'patient satisfaction', 'quality of life', 'arthroscopy' and 'hip'. A table outlining the search strategy is presented in [Appendix Table AI](#hnv048-T4){ref-type="table"}.

Study screening
---------------

Two reviewers independently screened the titles, abstracts and full texts of the retrieved studies. If at any point during the title and abstract screening phases, one reviewer believed an article should proceed to the next stage, it was included to ensure thoroughness. At the full text stage, any disagreements were first discussed by the two reviewers and unresolved conflicts mediated by a third reviewer until a consensus was reached. The references of included studies were further searched to capture any articles that may have been missed by the initial search strategy. A second list of references for the papers eliminated at the full text review stage can be found in Appendix A2.

Quality assessment of included studies
--------------------------------------

A quality assessment analysis of all the non-randomized included studies was done using a Methodological Index for Non-Randomized Studies (MINORS) Criteria \[[@hnv048-B15]\]. The MINORS criteria is a validated scoring tool for non-randomized studies. Each of the 12 items in the MINORS criteria is given a score of 0, 1 or 2 giving an ideal score of 16 for non-comparative studies and 24 for comparative studies. In the case of randomized studies the methodology was assessed using the Coleman Methodology Score which is a commonly used methodology scoring system (maximum score 100) in orthopaedic literature. The agreement between the two reviewers was calculated using an interclass correlation coefficient (ICC).

Data abstraction
----------------

Two reviewers independently abstracted study data from the final pool of included articles and recorded this data in Microsoft Excel (2013). Demographic information included author, year of publication, sample size, study design, level of evidence, patient demographics (i.e. sex, age, affected hip, etc.) and type of surgery. Additionally, a variety of outcome information was abstracted including pre-operative and post-operative standardized hip outcomes scores (mHHS, WOMAC, HOS-ADL, HOS-SSS, UCLA, SF-12 and NAHS) along with non-hip outcomes such as: improvement in pain, post-operative ROM, ability to return to sport and patient satisfaction. Finally, the number of patients requiring further surgery and any complication of treatment was also abstracted.

Statistical analysis
--------------------

A weighted κ (kappa) was calculated for each stage of article screening in order to evaluate inter-reviewer agreement \[[@hnv048-B16]\]. Agreement was categorized *a priori* as follows: κ \> 0.61 to indicate substantial agreement, 0.21 \< κ \< 0.60 to indicate moderate agreement, and κ \< 0.20 to indicate slight agreement \[[@hnv048-B17]\]. Descriptive statistics, such as means, ranges and confidence intervals (CI) are presented.

RESULTS
=======

Study identification
--------------------

Our initial literature search yielded 2243 studies, of which 33 met the inclusion and exclusion criteria for this review ([Fig. 1](#hnv048-F1){ref-type="fig"}). The characteristics of each of the included studies can be found in [Table I](#hnv048-T1){ref-type="table"}. There was excellent agreement among reviewers at the title (κ = 0.81; 95% CI, 0.78--0.84), abstract (κ = 0.76; 95% CI, 0.71--0.82) and full-text screening (κ = 1.0). Table I.Characteristics of included studiesPrimary authorLocationStudy designLevel of evidenceSample size---patients (hips)% maleMean age (years)Follow-upType of surgeryConsensus MINORS score (0--16 for non-comparative studies, 0--24 for comparative studies)Beaule *et al.* \[[@hnv048-B22]\]CanadaCase seriesIV34 (37)52.9%40.5 (19--54)3.1 (2.1--5.0)Surgical hip dislocation9Bizzini *et al.* \[[@hnv048-B23]\]SwitzerlandCase seriesIV5 (6)100%21.4 (20--22)32.2 (20--44)Surgical hip dislocation10Boone *et al.* \[[@hnv048-B24]\]USACase seriesIV21 (22)66.7%44 (40--5)3.8 (0.9--8.4) yearsSurgical hip dislocation10[^a^](#hnv048-TF1){ref-type="table-fn"}Domb *et al.* \[[@hnv048-B25]\]USAProspective matched-pairIIA: 10, B: 20A: 20%, B: 20%A: 19, B: 19.6A: 24.8 (12--39), B: 25.5 (21--34)A: surgical hip dislocation, B: arthroscopic20Ejnisman *et al.* \[[@hnv048-B26]\]USACase seriesIV7031%153 years (2--5)Arthroscopic11Gedouin *et al.* \[[@hnv048-B19]\]FranceCase seriesIV110 (111)70.9%31 (16--49)10 (6--18) monthsArthroscopic11Guanche *et al.* \[[@hnv048-B27]\]USACase seriesIV60(61)NAUnknown32.8 (21--48) monthsArthroscopic10Hartmann *et al.* \[[@hnv048-B18]\]GermanyCase seriesIV33(34)51.5%31(15--47)15 (6--27) monthsMini-open10Herrmann *et al.* \[[@hnv048-B28]\]GermanyCase seriesIV83Unknown48.6(40--65)26 monthsArthroscopic11Impellizzeri *et al.* \[[@hnv048-B9]\]SwitzerlandCase seriesIV17244%35.9 (11.5 SD)6 monthsArthroscopic and mini-open10Impellizzeri *et al.* \[[@hnv048-B29]\]SwitzerlandCase seriesIV16250%35 (12 SD)Minimum 12 monthsArthroscopic and mini-open surgery10Jackson *et al.* \[[@hnv048-B20]\]USACase seriesIV6637%28.8 ± 12.8 (14--57)2.4 ± 0.6 (1.7--4.1) yearsArthroscopy10Javed and O'Donnell \[[@hnv048-B30]\]AustraliaCase seriesIV40 (40)65%65 (60--82)30 (12--54) monthsArthroscopic9^b^Krych *et al.* \[[@hnv048-B31]\]USAProspective randomized control trialIA: 18, B: 180A: 38 (20--59), B: 39 (19--55)32 (12--48) monthsArthroscopicN/A^fc^Larson and Giveans \[[@hnv048-B32]\]USARetrospective comparative studyIIIA: 34 (36), B: 37 (39)A: 73.5%, B: 62.1%A: 31 (16--57), B: 26 (16--56)A: 21.4 (12--36) months, B: 16.5 (12--24) monthsArthroscopic16Lo and Guanche \[[@hnv048-B33]\]UnknownCase seriesIV94(100)UnknownUnknown60 (40--74) monthsArthroscopic8Malviya *et al.* \[[@hnv048-B34]\]UKCase seriesIV612 patients58%36.7 (14--75)3.2 (1--7) yearsArthroscopic11Mannion *et al.* \[[@hnv048-B14]\]SwitzerlandCase seriesIV12846%35.9 (SD: 12)Min 12 monthsArthroscopic or mini-open10^d^Matsuda *et al.* \[[@hnv048-B35]\]USAProspective comparative cohortIIA: 15 (18), B: 126 (130)A: 66.7%, B: 48.5%A: 37.2, B: 40.2NAArthroscopic15^e^Matsuda and Burchette \[[@hnv048-B36]\]USARetrospective comparative studyIIIA: 8(8), B: 46 (46)A: 87.5%, B: 54.0%A: 34.6 (18--58), B: 37.5 (18--73)A: 30 (24--37) months, B: NAArthroscopic17^f^Murata *et al.* \[[@hnv048-B37]\]JapanProspective comparative cohortIIA: 50, B: 37A: 64%, B: 32%A: 34.7, B: 42.5Minimum 12 monthsArthroscopic16Naal *et al.* \[[@hnv048-B21]\]SwitzerlandCase seriesIV192 (240)60%30.0 ± 9.3 (14--55)60.7 ± 11.8 (24--120) monthsSurgical hip dislocation10Palmer *et al.* \[[@hnv048-B38]\]USACase seriesIV185(201)49.3%40.2 (14--87)46 (36--NA) monthsArthroscopically12Park *et al.* \[[@hnv048-B39]\]South KoreaCase seriesIV197(200)49.2%44.6 (19--70)28.2 (19--42) monthsArthroscopy9Philippon *et al.* \[[@hnv048-B40]\]USACase seriesIV4593.3%31 (17--61)1.6 (0.5--5.5) yearsArthroscopy9Philippon *et al.* \[[@hnv048-B41]\]USACase seriesIV11244.6%40.6 (37.7--43.5)2.3 (2.0--2.9) yearsArthroscopic10Philippon *et al.* \[[@hnv048-B42]\]USACase seriesIV60(65)31%15 (11--16)3.5 (2--5) yearsArthroscopy10Philippon *et al.* \[[@hnv048-B43]\]USACase seriesIV15347%57 (50--77)35.7 (12--64) monthsArthroscopy9Polesello *et al.* \[[@hnv048-B44]\]BrazilCase seriesIV24(26)87.5%34 (13--51)6.1 (5--8) yearsArthroscopy7Singh *et al.* \[[@hnv048-B45]\]AustraliaCase seriesIV24(27)100%22 (16--29)22 (6--60) monthsArthroscopic10Sink *et al.* \[[@hnv048-B46]\]USACase seriesIV44 (52)15.9%16.2 (13--19)27 (12--60) monthsArthroscopic9Tran *et al.* \[[@hnv048-B47]\]AustraliaCase seriesIV34 (41)85.3%15.7 (11--18)14 months (1--2 years)Arthroscopic12Walker *et al.* \[[@hnv048-B48]\]USACase seriesIV19 (20)25%28.6 (16--50)26.4 (12--56) monthsSurgical hip dislocation10[^1]

Study characteristics
---------------------

All included studies were conducted between 2007 and 2014. This included a total of 3198 patients, with 281 patients treated by surgical hip dislocation, 33 mini-open procedures and 2422 arthroscopic procedures. A remaining 462 patients were treated with either arthroscopy, mini-open or combined procedures that were not otherwise specified. Mini-open procedures were performed according to the techniques developed by Clohisy or Hartmann *et al.* \[[@hnv048-B18]\]. Mean sample size of the included studies was 94 patients, 45.0% of which were female, with a mean age 33.6 years and mean follow-up 26.6 months.

Study quality
-------------

The majority of these studies were of level IV evidence (27 case series). Two studies were level III evidence, three studies were of level II evidence and a single arthroscopic study comparing labral debridement with labral repair was of level I evidence. There was high agreement amongst quality assessment scores of included studies using MINORS criteria, with ICC = 0.99. The included studies had an average MINORS score of 10/16 ([Table I](#hnv048-T1){ref-type="table"}). The one level I evidence study was methodologically assessed using the Coleman Methodology Score and received a score of 75/100.

Reported outcomes
-----------------

### A. Non-hip score outcomes

The most common non-hip score outcomes reported included: patient satisfaction as measured through a post-operative survey of patients (*n* = 21 studies, 72.7% of patients), symptom improvement (*n* = 7 studies, 24.7% of patients), pain improvement (*n* = 7 studies, 12.4% of patients), hip range of motion (*n* = 4 studies, 12.3% of patients) and return to sport (*n* = 6, 6.8% of patients) ([Table II](#hnv048-T2){ref-type="table"}). The majority (55--70%) of patients stated they had an 'acceptable state' of symptoms with only 12--17.6% of patients reported being unsatisfied with outcomes in post-operative surveys. It was found that 50--82% of patients had pain improvement among the two studies which specifically commented on this and average visual analog scores (VASs) ranged from 0 to 2.8 post-operatively across the six studies which reported this outcome. Across the studies, 60--100% of patients were able to return to pre-injury levels of competition. Bizzini *et al.* reported the lowest return to pre-injury sport (60%) in a small cohort of five professional hockey players, while the remainder of studies with larger cohorts reported 71.4--100% return to sport. The mean reported patient satisfaction across 21 studies was 85% when surveyed post-operatively. Furthermore, 81--100% of patients said that they would undergo the procedure again after being surveyed post-operatively across the four studies that reported this measure. Table II.Non-hip score outcomes reported in included studiesPrimary author, yearPatient satisfactionPainImprovement of overall symptomsReturn to sportROMOtherBeaule *et al.* \[[@hnv048-B22]\]17.6% with unsatisfactory outcomes.NRNRNRNRNRBizzini *et al.* \[[@hnv048-B23]\]NRPain score: 0NRReturn to practice 6.7 (5.5--9.5) months.Participation in first competitive game 9.6 (7--14) months.60% reached their pre-operative level of performanceReturn to pre-op Rom: 10.3 (8--13) weeksNRBoone *et al.* \[[@hnv048-B24]\]NR50% had pain reliefNRNRNRNR[^a^](#hnv048-TF2){ref-type="table-fn"}Domb *et al.* \[[@hnv048-B25]\]Satisfaction rating (1--10): **A**- 8.1, **B**- 9.2**A:** Post-op VAS: 2.8**B:** Post-op VAS: 2.0NRNRNRNREjnisman *et al.* \[[@hnv048-B26]\]Satisfaction rating (1--10)Patients not requiring revision: 10Patients requiring revision, after revision: 10NRNRNRNRNRGedouin *et al.* \[[@hnv048-B19]\]77% satisfied or very satisfied, 27% moderately satisfied, 12% disappointed.NRNRNRNRNRGuanche *et al.* \[[@hnv048-B27]\]Patient satisfaction: 80%NRNRNRNRNRHartmann and Gunther \[[@hnv048-B18]\]Patient satisfaction VAS (0--10): 787.8% of patients said they would undergo the surgery againNR81.2% reported improvement in symptoms, 18.8% reported no change in symptoms.NRNRAll patients returned to pre-operative occupation level within 6 weeks post-operatively.Herrmann and Hauschild \[[@hnv048-B28]\]NRNRSelf-reported improvement of symptoms of 84%.NRNRNRImpellizzeri *et al.* \[[@hnv048-B9]\]NRNRHow much did the operation help your hip problem?Helped a lot: 24%, Helped: 36%, helped only a little: 31%, did not help: 8%55% of patients reported an 'acceptable state'.NRNRIf you had to spend the rest of your life with the symptoms you have now how would you feel about it?Very satisfied: 13%, Somewhat satisfied: 27%, neither satisfied nor dissatisfied: 15%, Somewhat dissatisfied: 23%, Very dissatisfied: 22%.Impellizzeri *et al.* \[[@hnv048-B29]\]NRNR66.4% of patients said the operation 'helped' or 'helped a lot'70% of patients reported an 'acceptable state'.NRNRMost important change actually occurring as a result of surgery45.5% pain improvement, 16.2% improvement in general physical capacity, 10.1% improvement in walking capacity, 23.2% improvement in the ability to do sport, 5.0% improvement in independence in everyday activity.Jackson *et al.* \[[@hnv048-B20]\]Patient satisfaction (1--10): 8.6VAS: 2.3NRNRNRNRJaved and O'Donnell \[[@hnv048-B30]\]Satisfaction rate: 75%NRNRNRNRNR^b^Krych *et al.* \[[@hnv048-B31]\]NRNRNRNRNRSelf-described post-operative hip condition**A:** 72%---normal, 22%---near normal, 6% abnormal, 0% severely abnormal.**B:** 28%---normal, 50%---near normal, 17% abnormal, 6% severely abnormal.^c^Larson and Giveans \[[@hnv048-B32]\]NR**A:** VAS: ∼1.2**B:** VAS: ∼1.0NRNRNRNRLo and Guanche \[[@hnv048-B33]\]Patients satisfaction 70%NRNRNRNRNRMalviya *et al.* \[[@hnv048-B34]\]73.5% of patients were 'happy' with the results.NRNRNRNRQOLImproved 76.6%, unchanged 14.4%, deteriorated in 9.0%.QOL increased from 0.95 to 0.97.Mannion *et al.* \[[@hnv048-B14]\]NRNROverall effectiveness of treatmentHelped a lot (29%), helped (39%), helped only a little (21%), didn't help (9%), made things worse (2%)NRNRNR^d^Matsuda *et al.* \[[@hnv048-B35]\]Five-point likert satisfaction scale: **A**: 4.2 **B**: 4.2NRNRNRNRNR^e^Matsuda and Burchette \[[@hnv048-B36]\]A: 87.5% high satisfaction, 12.5% moderate satisfactionNRNRNRNRNR^f^Murata *et al.* \[[@hnv048-B37]\]NRNRNRA: 100% return to pre-injury activityNRNRNaal *et al.* \[[@hnv048-B21]\]47.4% very satisfied, 34.5% satisfied, 9.2% 'neither/nor', 3.9% dissatisfaction, 4.9% very dissatisfied54.1% said expectations were completely fulfilled, 32.7% said their expectations were largely fulfilled, 13.2% stated their expectations were only partially or not fulfilled81% of patients would undergo the same surgery againNR84.5% indicated that their overall health status would be acceptableNRHip flexionPre-op: 91.1Post-op: 96.0Self-described post-operative hip condition33.1% normal, 50.3% nearly normal, 13.9% abnormal, 2.7% severely abnormalPalmer *et al.* \[[@hnv048-B38]\]Satisfaction level of 75%VAS- 2.7NRNRNRNRPark *et al.* \[[@hnv048-B39]\]Patient satisfaction (1--10): 8.9NRNRNRNRNRPhilippon *et al.* \[[@hnv048-B40]\]NRNRNR93% returned to professional sport, 78% remained active at professional level at 1.6 years after hip arthroscopyNRNRPhilippon *et al.* \[[@hnv048-B41]\]Patient satisfaction (1--10): 9NRNRNRNRTime line to return to work1 week (15%),1--5 weeks (53%), 6--8 weeks (18%), 2--6 months (14%)Philippon *et al.* \[[@hnv048-B42]\]Patient satisfaction (1--10): 10NRNRNRNRNRPhilippon *et al.* \[[@hnv048-B43]\]Patient satisfaction (1--10): 9NRNRNRMean flexion: 109 (90--145)Mean internal rotation: 32 (10--55%)Mean external rotation: 39 (20--65)NRPolesello *et al.* \[[@hnv048-B44]\]100% patients satisfied with procedure100% would have the operation againNRNR71.4% returned to normal sporting activityNRNRSingh and O'Donnell \[[@hnv048-B45]\]100% patients satisfied with procedure100% would have the operation againNRNR95.8% returned to previous activity levelNRNRSink *et al.* \[[@hnv048-B46]\]NRNRNRNRFlexionPre-op: 97.5Post-op: 106.2Internal rotationPre-op: 18.19Post-op: 34Self-described post-operative hip condition78.9% excellent, 21.1% goodTran *et al.* \[[@hnv048-B47]\]88.2% patient satisfaction.NRNR78.1% were able to return to full competitive sports. 12.5% were able to return to lower level. 8.8% unable to returnNRNRWalker *et al.* \[[@hnv048-B48]\]NR82% said pain improved.88% said symptoms improved.NRNRNRPatients23253977892193941363Percentage of patients73.7%12.4%24.7%6.8%12.3%42.6%Number of papers reporting outcome2177648[^2]

### B. Standardized hip outcome scores

Standardized hip outcome scores reported included the mHHS (*n* = 15 studies, 41.2%), NAHS (*n* = 10 studies, 29.4%), HOS ADL (*n* = 8 studies, 26.5%), HOS SSS (*n* = 5 studies, 17.6%), WOMAC (*n* = 6 studies, 17.6%), UCLA (*n* = 4 studies, 14.7%) and SF-12 (*n* = 2 studies, 5.9%) scores among others. Mean improvement of mHHS was 23.4, NAHS 24.0, HOS ADL 24.3, HOS SSS 23.6, WOMAC 15.5 and UCLA 1.5 ([Table III](#hnv048-T3){ref-type="table"}). Although inconsistent outcome reporting prevented a formal comparison, these standardized hip outcome scores generally improved. Table III.Standardized hip outcome scores reported in included studiesPrimary author, yearmHHSNAHSHOS ADLHOS SSSWOMACUCLASF-12OtherBeaule *et al.* \[[@hnv048-B22]\]NRNRNRNRPre-op: 61.2Post-op: 81.4Pre-op: 4.8 Post-op: 7.5Physical componentPre-op: 37.3 Post-op: 45.6Mental componentPre-op: 46.4 Post-op: 51.2NRBizzini *et al.* \[[@hnv048-B23]\]NRNRNRNRNRNRNRNRBoone *et al.* \[[@hnv048-B24]\]NRNRNRNRNRPost-op: 7NRNR[^a^](#hnv048-TF3){ref-type="table-fn"}Domb *et al.* \[[@hnv048-B25]\]**A**: Pre-op: 69.6Post-op: 92**B**: Pre-op: 68.2Post-op: 92.4**A**: Pre-op: 67.4Post-op: 85.7**B**: Pre-op: 66.1Post-op: 94.2**A**: Pre-op: 68.6Post-op: 91.5**B**: Pre-op: 72.2Post-op: 95.3**A**: Pre-op: 53.8Post-op: 77.3**B**: Pre-op: 44.3Post-op: 87.1NRNRNRNREjnisman *et al.* \[[@hnv048-B26]\]Pre-op: 60 Post-op: 93NRNRNRNRNRNRNRGedouin *et al.* \[[@hnv048-B19]\]NRNRNRNRPre-op: 60.3 Post-op: 83NRNRNRGuanche *et al.* \[[@hnv048-B27]\]NRPre-op: 49.2 Post-op: 71.2NRNRPre-op: 67.2 Post-op: 72.8NRNRNRHartmann and Gunther \[[@hnv048-B18]\]Pre-op: 63.9 Post-op: 85.1NRNRNRNRNRNRNRHerrmann and Hauschild \[[@hnv048-B28]\]NRNRPost-op: 84NRNRNRNRNRImpellizzeri *et al.* \[[@hnv048-B9]\]NRNRNRNRPre-op: 33.2Post-op: 14.5Note: scored with 100 being worst and 0 being best in this study.NRNREQ-VASPre-op: 64.1Post-op: 75.9EQ-5DPre-op: 0.57Post-op: 0.75Impellizzeri *et al.* \[[@hnv048-B29]\]NRNRNRNRNRNRNROHSPre-op: 33.3Post-op: 41.6Jackson *et al.* \[[@hnv048-B20]\]Improvement: 25.5Improvement: 27.3Improvement Post-op: 23.2Improvement Post-op: 32.6NRNRNRNRJaved and O'Donnell \[[@hnv048-B30]\]Pre-op: 60.5Post-op: 79.7Pre-op: 62.1Post-op: 77.2NRNRNRNRNRNR^b^Krych *et al.* \[[@hnv048-B31]\]NRNRA-Pre-op: 68.2 Post-op: 91.2B-Pre-op: 60.2Post-op: 80.9NRNRNRNRNR^c^Larson and Giveans \[[@hnv048-B32]\]A-Pre-op: ∼64Post-op: 88.9B-Pre-op: ∼62Post-op: 94.3NRNRNRNRNRA-Pre-op: ∼62Post-op: ∼82B-Pre-op: ∼60Post-op: ∼84NRLo and Guanche \[[@hnv048-B33]\]NRPre-op: 48.9 Post-op: 78NRNRPre-op: 66.8 Post-op: 77NRNRNRMalviya *et al.* \[[@hnv048-B34]\]NRNRNRNRNRNRNRNRMannion *et al.* \[[@hnv048-B14]\]NRNRNRNRNRNRNRNR^d^Matsuda *et al.* \[[@hnv048-B35]\]NRA-Pre-op: 51.5Post-op: 74.1B-Pre-op: 54.8Post-op: 76.9NRNRNRNRNRNR^e^Matsuda and Burchette \[[@hnv048-B36]\]NRA-Pre-op: 41.9Post-op: 92.4B-Pre-op: 55.4Post-op: 77.9NRNRNRNRNRNR^f^Murata *et al.* \[[@hnv048-B37]\]A-Pre-op: 66.4Post-op: 96.5B-Pre-op: 63.9Post-op: 89.5NRNRNRNRNRNRNRNaal *et al.* \[[@hnv048-B21]\]NRNRPre-op: 75.6Post-op (satisfied): 81.3Post-op (unsatisfied): 46.6Pre-op: 89.0Post-op (satisfied): 92.8Post-op (unsatisfied): 72.7Pain componentPre-op: 10.3Post-op (satisfied): 6.5Post-op (unsatisfied): 28.6Stiffness componentPre-op: 15.9Post-op (satisfied): 13.1Post-op (unsatisfied): 30.2Function componentPre-op: 9.6Post-op (satisfied): 6.6Post-op (unsatisfied): 24.7Pre-op: 7.7Post-op (satisfied): 7.9Post-op (unsatisfied): 6.8Physical componentPre-op: 47.4Post-op (satisfied): 48.5Post-op (unsatisfied): 42.2Mental componentPre-op: 52.3Post-op (satisfied): 52.5Post-op (unsatisfied): 51.5NRPalmer *et al.* \[[@hnv048-B38]\]NRPre-op: 56.1Post-op: 78.2NRNRNRNRNRNRPark *et al.* \[[@hnv048-B39]\]Pre-op: 69.0Post-op: 80.4NRNRNRNRNRNRNRPhilippon *et al.* \[[@hnv048-B40]\]NRNRNRNRNRNRNRNRPhilippon *et al.* \[[@hnv048-B41]\]Pre-op: 58Post-op: 84.3Pre-op: 66Post-op: 81Pre-op: 43Post-op: 69Pre-op: 70Post-op: 87.8NRNRNRNRPhilippon *et al.* \[[@hnv048-B42]\]Pre-op: 57Post-op: 91NRPre-op: 38Post-op: 82NRNRNRNRNRPhilippon *et al.* \[[@hnv048-B43]\]Pre-op: 58Post-op: 84NRPre-op: 42Post-op: 72Pre-op: 66Post-op: 87NRNRPhysical componentPre-op: 38Post-op: 49Mental componentPre-op: 54Post-op: 53NRPolesello *et al.* \[[@hnv048-B44]\]Pre-op: 62.7Post-op: 90.9NRNRNRNRNRNRNRSingh and O'Donnell \[[@hnv048-B45]\]Pre-op: 86 Post-op: 96NRNRNRNRNRNRNRSink*et al.* \[[@hnv048-B46]\]Pre-op: 57.7Post-op: 85.8NRNRNRNRNRPhysical componentPre-op: 42.4Post-op: 50.5Mental componentPre-op: 51.9Post-op: 53.9NRTran *et al.* \[[@hnv048-B47]\]Pre-op: 77.4Post-op: 76.3Pre-op: 76.3Post-op: 93.2NRNRNRNRNRNRWalker *et al.* \[[@hnv048-B48]\]NRNRNRNRNRPost-op: 8.5NRNRPatients1237816732556662266491334Percentage of patients38.7%25.5%22.9%17.4%20.7%8.3%15.4%10.4%Number of papers reporting outcome1510856452[^3]

### C. Relationship between non-hip score outcomes and standardized hip outcome scores

No clear relationship between standardized hip outcome scores and non-hip score outcomes was able to be established due to the inconsistency of outcome reporting between studies.

### D. Complications

There were only 25 (0.8%) complications overall from the 3198 patients (3342 hip surgeries). These complications included: nine transient paresthesias that resolved over time, one scrotal skin burn from antiseptic solution, two anchor replacements, four pudendal nerve neuropraxias, two lateral femoral cutaneous nerve neuropraxias, two labral perforations, one labral tear and four femoral head scuffs \[[@hnv048-B19]\].

DISCUSSION
==========

This is the first systematic review to examine the reporting of non-hip score outcomes in patients treated surgically for FAI. The major finding was that the most commonly reported non-hip score outcomes included patient satisfaction (72.7%), symptom improvement (24.7%), pain improvement (12.4%), hip range of motion (12.3%) and return to sport (6.8%).The results of this review show that the majority of the 3198 patients undergoing FAI surgery (arthroscopic, mini-open, open, surgical hip dislocation) were satisfied post-operatively based off results from 21 studies which surveyed patients on satisfaction post-operatively. This systematic review focused on reporting non-hip score outcomes whereas previous literature has emphasized reporting on standardized hip scores \[[@hnv048-B7]\]. Only 12--17.6% of patients were unsatisfied with outcomes after surgery and 81--100% of patients reported that they would undergo FAI surgery again. In a subgroup of six studies primarily focused on athletes, 83.1% of patients were able to return to sport at a professional level or similar level of pre-injury activity. Surprisingly, return to sport was the least reported outcome in this review.

In attempt to determine any changes in the reporting of the various outcomes over time, the frequency of each outcome being reported was plotted against the year of publication (tables not included in this manuscript). Unfortunately, there were no clear trends, in large part due to the fact that all but three of the included studies were published in the last 4 years making it difficult to establish any sort of pattern over such a short time period.

Based on this systematic review, there appears to be differences between what patients consider to be an important outcome and what non-hip score outcomes are reported in the literature. Impellizzeri *et al.* \[[@hnv048-B9]\] found that reduction in hip pain was the most cited reason for pursuing surgery followed by ability to return to sport and general physical capacity. Interestingly, in this systematic review, pain improvement as a non-hip score outcome was only reported in 12.4% of the included studies. That being said many of the standardized hip outcome scores (i.e. mHHS, NAHS, etc.) have pain components included in their questionnaires. Furthermore, although pain and symptom improvement was discussed quite frequently in the literature, it is of concern that only 6.8% of the studies reported statistics on return to sport, in this young active population. This further lends credence to the fact that clinical trials should incorporate the outcomes that are most important to patients. Finally, with regards to hip outcome scores, Lodhia *et al.* \[[@hnv048-B8]\] conclude that the HOS has the most 'clinimetric evidence and is the most proven instrument' for use in the FAI patient population. However, despite this, the mHHS and NAHS were found to be more frequently reported in the literature. It is possible that the use of validated outcome measures in the FAI population needs further adoption.

The strength of this review lies in the use of a duplicate, systematic approach to review multiple databases ensuring a comprehensive review of literature. Furthermore, this review provides a unique focus on the reporting of non-hip score outcomes in surgical FAI treatment which has not been previously explored in a systematic review.

Given that the majority of the studies in this review were of low quality evidence, we are limited by potential bias due to a lack of control groups, heterogeneous outcomes reporting, and small sample sizes. In this study, an English-only search was conducted and therefore some relevant literature published in other languages may potentially be excluded. It has not escaped notice that this language restriction may introduce bias and limit generalizability, as different cultures may emphasize different outcomes as top priorities. Moreover, as most studies provide only a summary of their raw data it was not possible to delineate any correlations between outcomes such as patient satisfaction or return to sport, and demographic variables such as age and sex. Finally, it is possible that the age of the patient may impact their perception of outcomes, but our included studies did not provided sufficient data to support or refute this claim.

Future research should further explore what outcomes are most important to patients with FAI. Increased consistency is needed in the literature in the reporting of outcomes before a relationship between standardized hip score outcomes and non-hip score outcomes can be explored. Although Impellizzeri *et al.* \[[@hnv048-B9]\] specifically attempted to answer this question, additional efforts are required to ensure that future research focuses on outcomes that patients value. Specifically, a survey analysing how the importance of outcomes changes with demographic information such as age, sex and activity level would provide valuable information not currently provided in the literature. Furthermore, it is unclear in the literature if the post-operative patient surveys being used to measure certain outcomes (e.g. pain improvement, patient satisfaction) are the same across studies. However, unlike non-hip score outcomes, standardized hip scores have the advantage of higher reproducibility and objectivity given their more consistent format of surveying patients. This adds the potential for increased bias when comparing across studies if the outcomes are not being measured in the exact same way. Future research should also focus on developing standardized post-operative surveys for FAI patients that will help to increase the consistency of how these outcomes are measured allowing for better cross study comparisons.

CONCLUSION
==========

The most commonly reported non-hip score outcomes in the literature addressing surgical management of FAI are patient satisfaction, symptom improvement and pain improvement. Generally, patients report a high level of satisfaction when surveyed post-operatively. However, differences exist between what outcomes the literature suggests are patient important and what outcomes are actually reported. Most noticeably is the fact that pain reduction is reported 12.4 % of the time and return to sport is seldom reported in assessing the efficacy of FAI surgery (6.8%). Secondly, despite the literature suggesting that outcome measures such as the HOS has important use in the FAI patient population, other standardized hip score outcomes (mHHS and NAHS) are still more commonly employed. The results of this systematic review have significant clinical relevance as it allows future research to focus on outcomes which are currently under addressed.
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Appendix Table AI: **Search strategy**MEDLINEEMBASEPubMEDSearch strategy1. Exp 'quality of life'2. Exp patient satisfaction3. Exp hip joint4. Exp arthroscopy5. 1 or 26. 3 and 57. 4 and 58. 6 or 71. Exp patient satisfaction2. Exp 'quality of life'3. Exp hip/su \[surgery\]4. Exp hip arthroscopy5. 1 or 26. 3 and 57. 4 and 58. 6 or 7((((('Patient satisfaction') OR 'quality of life')) AND 'hip joint')) OR (((('patient satisfaction') OR 'quality of life')) AND 'arthroscopy').Number of papers retrieved8081061329

[^1]: ^a^Domb *et al.* \[[@hnv048-B25]\]---**A:** Surgical hip dislocation; **B:** Arthroscopic. ^b^Krych *et al.* \[[@hnv048-B31]\]---**A:** Labral repair; **B:** Labral debridement. ^c^Larson and Giveans \[[@hnv048-B32]\]---**A:** Labral debridement; **B:** Labral refixation. ^d^Matsuda *et al.* \[[@hnv048-B35]\]---**A:** Global FAI; **B:** Pincer FAI. ^e^Matsuda and Burchette \[[@hnv048-B36]\]---**A:** Labral reconstruction; **B:** Labral refixation. ^f^Murata *et al.* \[[@hnv048-B37]\]---**A:** Athlete; **B:** Non-athlete. ^g^Methodology analyzed using the Coleman methodology score as MINORs criteria can not be used in randomized studies. Coleman methodology score: 75/100.

[^2]: ^a^Domb *et al.* \[[@hnv048-B25]\]---**A:** Surgical hip dislocation; **B:** Arthroscopic. ^b^Krych *et al.* \[[@hnv048-B31]\]---**A:** Labral repair; **B:** Labral debridement. ^c^Larson and Giveans \[[@hnv048-B32]\]---**A:** Labral debridement; **B:** Labral refixation. ^d^Matsuda *et al.* \[[@hnv048-B35]\]---**A:** Global FAI; **B:** Pincer FAI**.** ^e^Matsuda and Burchette \[[@hnv048-B36]\]---**A:** Labral reconstruction; **B:** Labral refixation. ^f^Murata *et al.* \[[@hnv048-B37]\]---**A:** Athlete; **B:** Non-athlete

[^3]: ^a^Domb *et al.* \[[@hnv048-B25]\]---**A:** Surgical hip dislocation; **B:** Arthroscopic. ^b^Krych *et al.* \[[@hnv048-B31]\]---**A:** Labral repair; **B:** Labral debridement. ^c^Larson and Giveans \[[@hnv048-B32]\]---**A:** Labral debridement; **B:** Labral refixation. ^d^Matsuda *et al.* \[[@hnv048-B35]\]---**A:** Global FAI; **B:** Pincer FAI. ^e^Matsuda and Burchette \[[@hnv048-B36]\]---**A:** Labral reconstruction; **B:** Labral refixation. ^f^Murata *et al.* \[[@hnv048-B37]\]---**A:** Athlete; **B:** Non-athlete.
